CD274 and neoplasm: Tumors modulate the T cell response directly through the expression of inhibitory receptors such as PD-L1 or indirectly through production of inhibitory molecules that induce the accumulation of immunosuppressive cells and promote tumor-reactive T cell exhaustion within the TME (124).